DPYD, TYMS, TYMP, TK1, and TK2 Genetic Expressions as Response Markers in Locally Advanced Rectal Cancer Patients Treated with Fluoropyrimidine-Based Chemoradiotherapy

Lignende værker

• Pharmacogenetic variants in the DPYD, TYMS, CDA and MTHFR genes are clinically significant predictors of fluoropyrimidine toxicity
  af: Loganayagam, A, et al.
  Udgivet: (2013)
• Machine learning for predicting pathological complete response in patients with locally advanced rectal cancer after neoadjuvant chemoradiotherapy
  af: Huang, Chun-Ming, et al.
  Udgivet: (2020)
• Comparison of efficacy and safety of preoperative Chemoradiotherapy in locally advanced upper and middle/lower rectal cancer
  af: Huang, Ming-Yii, et al.
  Udgivet: (2018)
• Early closure of defunctioning stoma increases complications related to stoma closure after concurrent chemoradiotherapy and low anterior resection in patients with rectal cancer
  af: Yin, Tzu-Chieh, et al.
  Udgivet: (2017)
• An observational study of extending FOLFOX chemotherapy, lengthening the interval between radiotherapy and surgery, and enhancing pathological complete response rates in rectal cancer patients following preoperative chemoradiotherapy
  af: Chun-Ming Huang, et al.
  Udgivet: (2016-09-01)